8-K · 2026-11-10
CalciMedica, Inc. announces its Q3 2026 financial results, reflecting ongoing development in the pharmaceutical preparations sector.
| Name | CalciMedica, Inc. |
|---|---|
| CIK | 0001534133 |
| Tickers | CALC |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 452120079 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | 858-952-5500 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
CalciMedica, Inc. announces its Q3 2026 financial results, reflecting ongoing development in the pharmaceutical preparations sector.
539 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-19 | 4 | xslF345X06/form4-11192026_091133.xml | 0002165242-26-000003 | 5855 | ||||||
| 2026-11-19 | 3 | xslF345X06/form3-11192026_091114.xml | 0002165242-26-000002 | 23370 | ||||||
| 2026-11-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001649553-26-000142 | 005-91725 | 261558839 | 34 | 12210 | |||
| 2026-11-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001172661-26-005216 | 005-91725 | 261557927 | 34 | 10818 | |||
| 2026-11-16 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-127771 | 005-91725 | 261556429 | 34 | 17100 | |||
| 2026-11-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001440771-26-000029 | 005-91725 | 261555695 | 34 | 18983 | |||
| 2026-11-10 | 10-Q | 10-Q | 0001193125-26-455490 | 001-39538 | 261540555 | 34 | 12679438 | 1 | 1 | |
| 2026-11-10 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-454430 | 001-39538 | 261537933 | 34 | 466838 | 1 | 1 |
| 2026-11-05 | 4 | xslF345X06/form4-11052026_041104.xml | 0001576244-26-000006 | 5861 | ||||||
| 2026-10-16 | 8-K | 8-K | 5.02 | 0001193125-26-424203 | 001-39538 | 261466684 | 34 | 137065 | 1 | 1 |
| 2026-10-05 | 4 | xslF345X06/form4-10052026_091008.xml | 0001823197-26-000002 | 5963 | ||||||
| 2026-10-05 | 4 | xslF345X06/form4-10052026_091046.xml | 0001674797-26-000007 | 5977 | ||||||
| 2026-10-05 | 4 | xslF345X06/form4-10052026_091056.xml | 0001825009-26-000003 | 5956 | ||||||
| 2026-10-05 | 4 | xslF345X06/form4-10052026_091056.xml | 0001626850-26-000002 | 5956 | ||||||
| 2026-10-05 | 4 | xslF345X06/form4-10052026_091035.xml | 0001189022-26-000005 | 5954 | ||||||
| 2026-09-30 | 8-K | 8-K | 8.01,9.01 | 0001193125-26-409049 | 001-39538 | 261427227 | 34 | 160330 | 1 | 1 |
| 2026-09-30 | 424B5 | 424B5 | 0001193125-26-409041 | 333-293972 | 261427190 | 33 | 418728 | |||
| 2026-09-28 | 4 | xslF345X06/form4-09282026_080927.xml | 0001968793-26-000007 | 5853 | ||||||
| 2026-09-28 | 4 | xslF345X06/form4-09282026_080937.xml | 0001969388-26-000003 | 5862 | ||||||
| 2026-09-28 | 4 | xslF345X06/form4-09282026_080935.xml | 0001942596-26-000003 | 5849 | ||||||
| 2026-09-28 | 4 | xslF345X06/form4-09282026_080938.xml | 0001484729-26-000006 | 5875 | ||||||
| 2026-09-23 | S-8 | S-8 | 0001193125-26-399649 | 333-299099 | 261401735 | 33 | 201585 | 1 | 1 | |
| 2026-09-16 | 8-K | 8-K | 8.01 | 0001193125-26-393034 | 001-39538 | 261383676 | 34 | 138617 | 1 | 1 |
| 2026-09-02 | 8-K | 8-K | 8.01 | 0001193125-26-379419 | 001-39538 | 261352704 | 34 | 140646 | 1 | 1 |
| 2026-08-27 | 8-K | 8-K | 5.03,9.01 | 0001193125-26-369713 | 001-39538 | 261325525 | 34 | 163996 | 1 | 1 |
| 2026-08-25 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001440771-26-000018 | 005-91725 | 261316104 | 34 | 19293 | |||
| 2026-08-24 | 4 | FORM 4 | 0000912282-26-001157 | 8616 | ||||||
| 2026-08-24 | SCHEDULE 13D/A | xslSCHEDULE_13D_X02/primary_doc.xml | 0000912282-26-001155 | 005-91725 | 261311455 | 34 | 184133 | |||
| 2026-08-21 | 4 | xslF345X06/form4-08212026_100848.xml | 0001626850-26-000001 | 5953 | ||||||
| 2026-08-21 | 4 | xslF345X06/form4-08212026_100824.xml | 0001823197-26-000001 | 5961 | ||||||
| 2026-08-21 | 4 | xslF345X06/form4-08212026_100850.xml | 0001825009-26-000002 | 5954 | ||||||
| 2026-08-21 | 4 | xslF345X06/form4-08212026_100845.xml | 0001674797-26-000006 | 13222 | ||||||
| 2026-08-21 | 4 | xslF345X06/form4-08212026_100838.xml | 0001189022-26-000004 | 11723 | ||||||
| 2026-08-21 | 4 | xslF345X06/form4-08212026_100852.xml | 0001968793-26-000006 | 9276 | ||||||
| 2026-08-21 | 4 | xslF345X06/form4-08212026_100837.xml | 0001576244-26-000005 | 9941 | ||||||
| 2026-08-21 | 4 | xslF345X06/form4-08212026_100832.xml | 0001484729-26-000005 | 9336 | ||||||
| 2026-08-21 | SCHEDULE 13D/A | xslSCHEDULE_13D_X02/primary_doc.xml | 0001193125-26-361273 | 005-91725 | 261305593 | 34 | 20349 | |||
| 2026-08-20 | 8-K | 8-K | 5.02,5.07,9.01 | 0001193125-26-357258 | 001-39538 | 261296769 | 34 | 387947 | 1 | 1 |
| 2026-08-14 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000919574-26-005261 | 005-91725 | 261277843 | 34 | 9628 | |||
| 2026-08-14 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001172661-26-003558 | 005-91725 | 261277032 | 34 | 10707 | |||
| 2026-08-11 | 10-Q | 10-Q | 0001193125-26-344689 | 001-39538 | 261263415 | 34 | 11409323 | 1 | 1 | |
| 2026-08-11 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-343428 | 001-39538 | 261260607 | 34 | 447866 | 1 | 1 |
| 2026-07-31 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-002514 | 333-297681 | 261230203 | 33 | 2040 | ||
| 2026-07-24 | S-3 | S-3 | 0001193125-26-316100 | 333-297681 | 261201621 | 33 | 658808 | 1 | 1 | |
| 2026-07-23 | ARS | ARS | 0001193125-26-314090 | 001-39538 | 261197099 | 34 | 2735491 | |||
| 2026-07-23 | DEF 14A | DEF 14A | 0001193125-26-314085 | 001-39538 | 261197070 | 34 | 3794591 | 1 | 1 | |
| 2026-07-20 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001649553-26-000074 | 005-91725 | 261187632 | 34 | 15740 | |||
| 2026-07-13 | PRE 14A | PRE 14A | 0001193125-26-302112 | 001-39538 | 261171881 | 34 | 3724957 | 1 | 1 | |
| 2026-07-10 | 3 | FORM 3 | 0000912282-26-000963 | 5464 | ||||||
| 2026-07-10 | SCHEDULE 13D | xslSCHEDULE_13D_X02/primary_doc.xml | 0000912282-26-000961 | 005-91725 | 261169552 | 34 | 195990 | |||
| 2026-07-07 | 4 | xslF345X06/form4-07072026_090755.xml | 0001674797-26-000004 | 5854 | ||||||
| 2026-07-07 | 3 | xslF345X06/form3-07072026_080730.xml | 0001674797-26-000003 | 12755 | ||||||
| 2026-07-07 | 8-K | 8-K | 5.02 | 0001193125-26-297475 | 001-39538 | 261159452 | 34 | 153846 | 1 | 1 |
| 2026-07-02 | SCHEDULE 13D | xslSCHEDULE_13D_X02/primary_doc.xml | 0001193125-26-295162 | 005-91725 | 261153860 | 34 | 140169 | |||
| 2026-06-30 | SCHEDULE 13D/A | xslSCHEDULE_13D_X02/primary_doc.xml | 0000912282-26-000883 | 005-91725 | 261141903 | 34 | 20479 | |||
| 2026-06-29 | 4 | xslF345X06/form4-06292026_080608.xml | 0001267959-26-000003 | 15078 | ||||||
| 2026-06-29 | 4 | xslF345X06/form4-06292026_080607.xml | 0001968793-26-000004 | 5410 | ||||||
| 2026-06-29 | 4 | xslF345X06/form4-06292026_080605.xml | 0001189022-26-000002 | 5386 | ||||||
| 2026-06-29 | 4 | xslF345X06/form4-06292026_080603.xml | 0001576244-26-000004 | 10391 | ||||||
| 2026-06-29 | 4 | xslF345X06/form4-06292026_080601.xml | 0001484729-26-000004 | 9611 | ||||||
| 2026-06-25 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001829126-26-006875 | 005-91725 | 261122842 | 34 | 21838 | |||
| 2026-06-24 | 8-K | 8-K | 1.01,3.02,7.01,8.01,9.01 | 0001193125-26-281246 | 001-39538 | 261116703 | 34 | 5249004 | 1 | 1 |
| 2026-06-24 | 8-K | 8-K | 1.01,3.02,9.01 | 0001193125-26-280223 | 001-39538 | 261112962 | 34 | 421061 | 1 | 1 |
| 2026-05-20 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000921895-26-001458 | 005-91725 | 261005259 | 34 | 7402 | |||
| 2026-05-12 | 10-Q | 10-Q | 0001193125-26-219426 | 001-39538 | 26968589 | 34 | 10252326 | 1 | 1 | |
| 2026-05-12 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-218134 | 001-39538 | 26965805 | 34 | 399656 | 1 | 1 |
| 2026-05-08 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001213900-26-053986 | 005-91725 | 26959472 | 34 | 30813 | |||
| 2026-04-30 | 10-K/A | 10-K/A | 0001193125-26-197104 | 001-39538 | 26924758 | 34 | 1788056 | 1 | 1 | |
| 2026-04-07 | 4 | xslF345X06/form4-04072026_090411.xml | 0001942596-26-000002 | 6175 | ||||||
| 2026-04-07 | 4 | xslF345X06/form4-04072026_090409.xml | 0001968793-26-000002 | 6179 | ||||||
| 2026-04-07 | 4 | xslF345X06/form4-04072026_090407.xml | 0001576244-26-000002 | 6178 | ||||||
| 2026-04-07 | 4 | xslF345X06/form4-04072026_090405.xml | 0001968792-26-000002 | 6173 | ||||||
| 2026-04-07 | 4 | xslF345X06/form4-04072026_090404.xml | 0001969388-26-000002 | 6188 | ||||||
| 2026-04-07 | 4 | xslF345X06/form4-04072026_090402.xml | 0001484729-26-000002 | 6203 | ||||||
| 2026-03-18 | 8-K | 8-K | 3.01 | 0001193125-26-114096 | 001-39538 | 26769617 | 34 | 142437 | 1 | 1 |
| 2026-03-11 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-000798 | 333-293972 | 26745489 | 33 | 2039 | ||
| 2026-03-09 | CORRESP | filename1.htm | 0001193125-26-098556 | 7111 | ||||||
| 2026-03-06 | UPLOAD | filename1.pdf | 0000000000-26-002366 | 333-293972 | 40352 | |||||
| 2026-03-03 | S-3 | S-3 | 0001193125-26-088562 | 333-293972 | 26715785 | 33 | 1154780 | 1 | 1 | |
| 2026-03-03 | 10-K | 10-K | 0001193125-26-088147 | 001-39538 | 26713953 | 34 | 20476808 | 1 | 1 | |
| 2026-03-03 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-086658 | 001-39538 | 26711039 | 34 | 392226 | 1 | 1 |
| 2026-02-06 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001193805-26-000113 | 005-91725 | 26609199 | 34 | 17012 | |||
| 2026-01-28 | 8-K | 8-K | 8.01 | 0001193125-26-027462 | 001-39538 | 26573770 | 34 | 140495 | 1 | 1 |
| 2026-01-28 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-26-025649 | 001-39538 | 26568193 | 34 | 170042 | 1 | 1 |
| 2025-12-01 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0002042077-25-000016 | 005-91725 | 251539038 | 34 | 6347 | |||
| 2025-11-12 | 10-Q | 10-Q | 0001193125-25-277617 | 001-39538 | 251472947 | 34 | 11742786 | 1 | 1 | |
| 2025-11-12 | 8-K | 8-K | 2.02,9.01 | 0001193125-25-275888 | 001-39538 | 251468773 | 34 | 492244 | 1 | 1 |
| 2025-11-07 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001213900-25-107608 | 005-91725 | 251462438 | 34 | 30278 | |||
| 2025-11-06 | 8-K | 8-K | 8.01,9.01 | 0001193125-25-269526 | 001-39538 | 251458379 | 34 | 161743 | 1 | 1 |
| 2025-11-06 | 424B5 | 424B5 | 0001193125-25-269496 | 333-273949 | 251458216 | 33 | 14976 | |||
| 2025-10-29 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-25-103689 | 005-91725 | 251429593 | 34 | 17563 | |||
| 2025-10-14 | 4 | xslF345X05/form4-10142025_041014.xml | 0001823197-25-000003 | 5669 | ||||||
| 2025-09-22 | 4 | xslF345X05/form4-09222025_090901.xml | 0001576244-25-000007 | 9213 | ||||||
| 2025-09-17 | 4 | xslF345X05/form4-09172025_090902.xml | 0001576244-25-000005 | 9611 | ||||||
| 2025-09-15 | 4 | xslF345X05/form4-09152025_040948.xml | 0001576244-25-000003 | 9213 | ||||||
| 2025-09-11 | 4 | xslF345X05/form4-09112025_120901.xml | 0001415889-25-024256 | 9611 | ||||||
| 2025-09-09 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001829126-25-007253 | 005-91725 | 251303572 | 34 | 18782 | |||
| 2025-09-02 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001829126-25-007019 | 005-91725 | 251287145 | 34 | 16510 | |||
| 2025-09-02 | 4 | xslF345X05/form4-09022025_050918.xml | 0001415889-25-023364 | 11129 | ||||||
| 2025-08-25 | 4 | xslF345X05/form4-08252025_090801.xml | 0001415889-25-022850 | 9611 | ||||||
| 2025-08-21 | 4 | xslF345X05/form4-08212025_120804.xml | 0001415889-25-022550 | 13728 | ||||||
| 2025-08-21 | 4 | xslF345X05/form4-08212025_120801.xml | 0001415889-25-022549 | 5281 | ||||||
| 2025-08-19 | 4 | xslF345X05/form4-08192025_010801.xml | 0001415889-25-022261 | 9611 | ||||||
| 2025-08-18 | 4 | xslF345X05/form4-08182025_120801.xml | 0001415889-25-022159 | 7142 | ||||||
| 2025-08-12 | 10-Q | 10-Q | 0000950170-25-107334 | 001-39538 | 251206894 | 34 | 11385695 | 1 | 1 | |
| 2025-08-12 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-106918 | 001-39538 | 251204027 | 34 | 492489 | 1 | 1 |
| 2025-08-05 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-25-074358 | 005-91725 | 251186754 | 34 | 9455 | |||
| 2025-07-29 | 4 | xslF345X05/form4-07292025_040701.xml | 0001415889-25-020458 | 7010 | ||||||
| 2025-07-23 | 4 | xslF345X05/form4-07232025_030740.xml | 0001415889-25-020164 | 9214 | ||||||
| 2025-07-22 | 4 | xslF345X05/form4-07222025_040709.xml | 0001415889-25-020111 | 9609 | ||||||
| 2025-07-21 | 4 | xslF345X05/form4-07212025_060739.xml | 0001415889-25-020052 | 8432 | ||||||
| 2025-07-18 | 4 | xslF345X05/form4-07182025_060737.xml | 0001415889-25-019998 | 4858 | ||||||
| 2025-07-18 | 4 | xslF345X05/form4-07182025_060757.xml | 0001415889-25-019997 | 9213 | ||||||
| 2025-07-16 | 4 | xslF345X05/form4-07162025_040730.xml | 0001415889-25-019822 | 9611 | ||||||
| 2025-07-15 | 4 | xslF345X05/form4-07162025_010710.xml | 0001415889-25-019816 | 8433 | ||||||
| 2025-07-10 | 4 | xslF345X05/form4-07112025_120755.xml | 0001415889-25-019655 | 9215 | ||||||
| 2025-07-02 | 4 | xslF345X05/form4-07032025_010721.xml | 0001415889-25-019190 | 5577 | ||||||
| 2025-06-27 | 4 | xslF345X05/form4-06272025_110619.xml | 0001415889-25-018438 | 9613 | ||||||
| 2025-06-27 | S-8 POS | S-8 POS | 0001193125-25-151240 | 333-288287 | 251086209 | 33 | 35729 | |||
| 2025-06-27 | 8-K | 8-K | 5.02,5.07,9.01 | 0001193125-25-151234 | 001-39538 | 251086160 | 34 | 159902 | 1 | 1 |
| 2025-06-26 | 4 | xslF345X05/form4-06262025_100630.xml | 0001415889-25-018310 | 6034 | ||||||
| 2025-06-26 | 4 | xslF345X05/form4-06262025_100618.xml | 0001415889-25-018309 | 9212 | ||||||
| 2025-06-26 | 4 | xslF345X05/form4-06262025_100610.xml | 0001415889-25-018308 | 6043 | ||||||
| 2025-06-26 | 4 | xslF345X05/form4-06262025_100613.xml | 0001415889-25-018307 | 6033 | ||||||
| 2025-06-26 | 4 | xslF345X05/form4-06262025_100621.xml | 0001415889-25-018306 | 6028 | ||||||
| 2025-06-26 | 4 | xslF345X05/form4-06262025_100619.xml | 0001415889-25-018305 | 6055 | ||||||
| 2025-06-26 | 4 | xslF345X05/form4-06262025_100609.xml | 0001415889-25-018304 | 13084 | ||||||
| 2025-06-26 | 4 | xslF345X05/form4-06262025_100646.xml | 0001415889-25-018303 | 13078 | ||||||
| 2025-06-26 | 4 | xslF345X05/form4-06262025_100625.xml | 0001415889-25-018300 | 13061 | ||||||
| 2025-06-26 | 4 | xslF345X05/form4-06262025_100600.xml | 0001415889-25-018298 | 13071 | ||||||
| 2025-06-26 | 4 | xslF345X05/form4-06262025_100629.xml | 0001415889-25-018297 | 13051 | ||||||
| 2025-06-24 | S-8 | S-8 | 0001193125-25-145764 | 333-288287 | 251069645 | 33 | 231983 | |||
| 2025-06-13 | 4 | xslF345X05/form4-06132025_050601.xml | 0001415889-25-017250 | 9213 | ||||||
| 2025-06-09 | 4 | xslF345X05/form4-06092025_080603.xml | 0001415889-25-016218 | 11520 | ||||||
| 2025-06-09 | DEFA14A | DEFA14A | 0001193125-25-137807 | 001-39538 | 251034007 | 34 | 15679 | |||
| 2025-06-06 | 8-K | 8-K | 4.01,9.01 | 0001193125-25-136297 | 001-39538 | 251028857 | 34 | 149383 | 1 | 1 |
| 2025-06-03 | 4 | xslF345X05/form4-06032025_050601.xml | 0001415889-25-015421 | 4860 | ||||||
| 2025-05-28 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001829126-25-004015 | 005-91725 | 25997127 | 34 | 40108 | |||
| 2025-05-14 | 10-Q | 10-Q | 0000950170-25-071421 | 001-39538 | 25945743 | 34 | 10465983 | 1 | 1 | |
| 2025-05-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000935836-25-000330 | 005-91725 | 25945434 | 34 | 19521 | |||
| 2025-05-14 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-070910 | 001-39538 | 25942647 | 34 | 471104 | 1 | 1 |
| 2025-04-30 | ARS | ARS | 0001193125-25-104121 | 001-39538 | 25889735 | 34 | 7465344 | |||
| 2025-04-30 | DEFA14A | DEFA14A | 0001193125-25-104114 | 001-39538 | 25889715 | 34 | 523364 | |||
| 2025-04-29 | DEF 14A | DEF 14A | 0000950170-25-060362 | 001-39538 | 25889667 | 34 | 13679075 | 1 | 1 | |
| 2025-04-25 | 4 | xslF345X05/form4-04252025_080459.xml | 0001415889-25-011365 | 5701 | ||||||
| 2025-04-25 | 4 | xslF345X05/form4-04252025_080402.xml | 0001415889-25-011362 | 5714 | ||||||
| 2025-04-25 | 4 | xslF345X05/form4-04252025_080404.xml | 0001415889-25-011361 | 5699 | ||||||
| 2025-04-25 | 4 | xslF345X05/form4-04252025_080421.xml | 0001415889-25-011360 | 5704 | ||||||
| 2025-04-25 | 4 | xslF345X05/form4-04252025_080420.xml | 0001415889-25-011359 | 5705 | ||||||
| 2025-04-25 | 4 | xslF345X05/form4-04252025_080419.xml | 0001415889-25-011358 | 5726 | ||||||
| 2025-04-01 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-25-030774 | 005-91725 | 25801675 | 34 | 12592 | |||
| 2025-03-27 | 10-K | 10-K | 0000950170-25-046035 | 001-39538 | 25779161 | 34 | 24112356 | 1 | 1 | |
| 2025-03-27 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-045729 | 001-39538 | 25775303 | 34 | 437947 | 1 | 1 |
| 2025-03-05 | 8-K | 8-K | 1.01,2.03,3.02,8.01,9.01 | 0001193125-25-046225 | 001-39538 | 25708804 | 34 | 652049 | 1 | 1 |
| 2025-03-04 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-25-044830 | 001-39538 | 25701501 | 34 | 194116 | 1 | 1 |
| 2025-03-03 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-25-019840 | 005-91725 | 25699198 | 34 | 13868 | |||
| 2025-02-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000950170-25-020607 | 005-91725 | 25624834 | 34 | 12601 | |||
| 2025-01-16 | 4 | xslF345X05/form4-01172025_120159.xml | 0001415889-25-001595 | 5702 | ||||||
| 2025-01-16 | 3 | xslF345X02/form3-01172025_120145.xml | 0001415889-25-001594 | 8244 | ||||||
| 2025-01-14 | 8-K | 8-K | 5.02 | 0001193125-25-005654 | 001-39538 | 25527744 | 34 | 152050 | 1 | 1 |
| 2024-12-20 | 8-K | 8-K | 8.01,9.01 | 0001193125-24-283105 | 001-39538 | 241567947 | 34 | 171067 | 1 | 1 |
| 2024-12-20 | 424B5 | 424B5 | 0001193125-24-283094 | 333-273949 | 241567883 | 33 | 467350 | |||
| 2024-12-13 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000935836-24-000758 | 005-91725 | 241547990 | 34 | 19638 | |||
| 2024-12-06 | 4 | xslF345X05/form4-12072024_121223.xml | 0001415889-24-028563 | 14476 | ||||||
| 2024-11-26 | SC 13D | SC 13D | 0001193125-24-265556 | 005-91725 | 241498000 | 34 | 258611 | |||
| 2024-11-15 | 3 | xslF345X02/form3-11152024_091150.xml | 0001415889-24-026941 | 12570 | ||||||
| 2024-11-14 | SC 13G/A | AMENDMENT NO. 2 TO SCHEDULE 13G | 0001213900-24-098327 | 005-91725 | 241461045 | 34 | 202544 | |||
| 2024-11-14 | SC 13G/A | calc13ga1.htm | 0000935836-24-000691 | 005-91725 | 241459694 | 34 | 29128 | |||
| 2024-11-13 | SC 13G/A | calc13ga1.htm | 0000935836-24-000667 | 005-91725 | 241455855 | 34 | 61244 | |||
| 2024-11-13 | 10-Q | 10-Q | 0000950170-24-126296 | 001-39538 | 241454052 | 34 | 9219892 | 1 | 1 | |
| 2024-11-13 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-125933 | 001-39538 | 241451161 | 34 | 370651 | 1 | 1 |
| 2024-11-08 | 8-K | 8-K | 5.02 | 0001193125-24-253754 | 001-39538 | 241438141 | 34 | 158512 | 1 | 1 |
| 2024-11-06 | 4/A | xslF345X05/form4a-11062024_081102.xml | 0001415889-24-026280 | 5499 | ||||||
| 2024-11-06 | SC 13D/A | SC 13D/A | 0001193125-24-252056 | 005-91725 | 241431258 | 34 | 111644 | |||
| 2024-11-05 | 4 | xslF345X05/form4-11052024_081117.xml | 0001415889-24-026103 | 26065 | ||||||
| 2024-11-05 | 4 | xslF345X05/form4-11052024_081149.xml | 0001415889-24-026102 | 16056 | ||||||
| 2024-11-01 | 4 | xslF345X05/form4-11012024_051148.xml | 0001415889-24-025880 | 7726 | ||||||
| 2024-11-01 | 4 | xslF345X05/form4-11012024_051115.xml | 0001415889-24-025878 | 9221 | ||||||
| 2024-11-01 | 4 | xslF345X05/form4-11012024_051102.xml | 0001415889-24-025876 | 4866 | ||||||
| 2024-10-31 | 8-K | 8-K | 1.01,8.01,9.01 | 0001193125-24-248761 | 001-39538 | 241415871 | 34 | 421643 | 1 | 1 |
| 2024-10-31 | 424B5 | 424B5 | 0001193125-24-248759 | 333-273949 | 241415840 | 33 | 625083 | |||
| 2024-10-30 | 424B5 | 424B5 | 0001193125-24-247665 | 333-273949 | 241411512 | 33 | 626240 | |||
| 2024-10-30 | 8-K | 8-K | 2.02,8.01,9.01 | 0001193125-24-247643 | 001-39538 | 241411164 | 34 | 180464 | 1 | 1 |
| 2024-10-30 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-24-247004 | 001-39538 | 241407448 | 34 | 13876735 | 1 | 1 |
| 2024-09-11 | 4 | xslF345X05/form4-09112024_050902.xml | 0001415889-24-023226 | 8038 | ||||||
| 2024-08-28 | 4 | xslF345X05/form4-08282024_110854.xml | 0001415889-24-022509 | 5699 | ||||||
| 2024-08-28 | 4 | xslF345X05/form4-08282024_110809.xml | 0001415889-24-022508 | 5644 | ||||||
| 2024-08-28 | 4 | xslF345X05/form4-08282024_110830.xml | 0001415889-24-022507 | 5675 | ||||||
| 2024-08-28 | 4 | xslF345X05/form4-08282024_110840.xml | 0001415889-24-022506 | 5665 | ||||||
| 2024-08-28 | 4 | xslF345X05/form4-08282024_110857.xml | 0001415889-24-022505 | 5682 | ||||||
| 2024-08-28 | 4 | xslF345X05/form4-08282024_110824.xml | 0001415889-24-022504 | 5703 | ||||||
| 2024-08-28 | 4 | xslF345X05/form4-08282024_110845.xml | 0001415889-24-022503 | 5718 | ||||||
| 2024-08-28 | 4 | xslF345X05/form4-08282024_110858.xml | 0001415889-24-022502 | 5708 | ||||||
| 2024-08-28 | 4 | xslF345X05/form4-08282024_110856.xml | 0001415889-24-022501 | 5709 | ||||||
| 2024-08-28 | 4 | xslF345X05/form4-08282024_110856.xml | 0001415889-24-022500 | 5733 | ||||||
| 2024-08-27 | 4 | xslF345X05/form4-08272024_110843.xml | 0001415889-24-022361 | 8123 | ||||||
| 2024-08-27 | S-8 | S-8 | 0001193125-24-207811 | 333-281800 | 241249715 | 33 | 71505 | |||
| 2024-08-27 | 8-K | 8-K | 5.02,5.07,9.01 | 0001193125-24-207754 | 001-39538 | 241249012 | 34 | 366150 | 1 | 1 |
| 2024-08-26 | 4 | xslF345X05/form4-08262024_090856.xml | 0001415889-24-022243 | 10016 | ||||||
| 2024-08-26 | 4 | xslF345X05/form4-08262024_090826.xml | 0001415889-24-022242 | 5262 | ||||||
| 2024-08-22 | 4 | xslF345X05/form4-08222024_100832.xml | 0001415889-24-022058 | 9220 | ||||||
| 2024-08-12 | 10-Q | 10-Q | 0000950170-24-095490 | 001-39538 | 241197197 | 34 | 8751641 | 1 | 1 | |
| 2024-08-12 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-095450 | 001-39538 | 241196977 | 34 | 342666 | 1 | 1 |
| 2024-07-16 | ARS | ARS | 0001193125-24-179349 | 001-39538 | 241118611 | 34 | 6797189 | |||
| 2024-07-16 | DEFA14A | DEFA14A | 0001193125-24-179346 | 001-39538 | 241118602 | 34 | 497154 | |||
| 2024-07-16 | DEF 14A | DEF 14A | 0001193125-24-179344 | 001-39538 | 241118599 | 34 | 1219897 | |||
| 2024-07-08 | SC 13G | calc13g.htm | 0000935836-24-000467 | 005-91725 | 241103980 | 34 | 30272 | |||
| 2024-07-02 | 4 | xslF345X05/form4-07022024_080711.xml | 0001415889-24-018934 | 5264 | ||||||
| 2024-07-01 | 4 | xslF345X05/form4-07012024_070708.xml | 0001415889-24-018567 | 5261 | ||||||
| 2024-06-28 | 4 | xslF345X05/form4-06282024_100627.xml | 0001415889-24-018496 | 9220 | ||||||
| 2024-06-27 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-24-169805 | 001-39538 | 241075542 | 34 | 5387256 | 1 | 1 |
| 2024-05-20 | 4 | xslF345X05/form4-05202024_110554.xml | 0001415889-24-013834 | 5803 | ||||||
| 2024-05-13 | 10-Q | 10-Q | 0000950170-24-058744 | 001-39538 | 24939819 | 34 | 7783673 | 1 | 1 | |
| 2024-05-13 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-058730 | 001-39538 | 24939739 | 34 | 343305 | 1 | 1 |
| 2024-04-29 | 10-K/A | 10-K/A | 0001193125-24-120151 | 001-39538 | 24886693 | 34 | 728874 | 1 | 1 | |
| 2024-04-22 | 4 | xslF345X05/form4-04232024_010415.xml | 0001415889-24-011354 | 5701 | ||||||
| 2024-04-22 | 4 | xslF345X05/form4-04232024_010410.xml | 0001415889-24-011353 | 5646 | ||||||
| 2024-04-22 | 4 | xslF345X05/form4-04232024_010404.xml | 0001415889-24-011352 | 5677 | ||||||
| 2024-04-22 | 4 | xslF345X05/form4-04232024_010401.xml | 0001415889-24-011351 | 5667 | ||||||
| 2024-04-22 | 4 | xslF345X05/form4-04232024_010454.xml | 0001415889-24-011350 | 5684 | ||||||
| 2024-04-22 | 4 | xslF345X05/form4-04232024_010442.xml | 0001415889-24-011349 | 5705 | ||||||
| 2024-04-22 | 4 | xslF345X05/form4-04232024_010428.xml | 0001415889-24-011348 | 5720 | ||||||
| 2024-04-22 | 4 | xslF345X05/form4-04232024_010420.xml | 0001415889-24-011346 | 5710 | ||||||
| 2024-04-22 | 4 | xslF345X05/form4-04232024_010443.xml | 0001415889-24-011344 | 5711 | ||||||
| 2024-04-22 | 4 | xslF345X05/form4-04232024_010439.xml | 0001415889-24-011343 | 5735 | ||||||
| 2024-04-10 | 8-K | 8-K | 4.01,9.01 | 0001193125-24-092036 | 001-39538 | 24836561 | 34 | 158037 | 1 | 1 |
| 2024-04-02 | 4 | xslF345X05/form4-04032024_120452.xml | 0001415889-24-009884 | 10754 | ||||||
| 2024-03-29 | 8-K | 8-K | 8.01,9.01 | 0001193125-24-081584 | 001-39538 | 24802126 | 34 | 171687 | 1 | 1 |
| 2024-03-29 | 424B5 | 424B5 | 0001193125-24-081580 | 333-273949 | 24802119 | 33 | 14344 | |||
| 2024-03-28 | S-8 | S-8 | 0001193125-24-080792 | 333-278336 | 24799940 | 33 | 68179 | |||
| 2024-03-28 | 10-K | 10-K | 0000950170-24-038064 | 001-39538 | 24799247 | 34 | 15546637 | 1 | 1 | |
| 2024-03-28 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-037609 | 001-39538 | 24793478 | 34 | 391255 | 1 | 1 |
| 2024-02-13 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-24-033981 | 001-39538 | 24630261 | 34 | 10226591 | 1 | 1 |
| 2024-02-09 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2024-02-09 16:00:00 | 9999999995-24-000374 | 333-276793 | 24617186 | 33 | 2046 | ||
| 2024-02-08 | SC 13D/A | SC 13D/A | 0001193125-24-028560 | 005-91725 | 24610482 | 34 | 105111 | |||
| 2024-02-08 | SC 13G/A | AMENDMENT NO. 1 TO SCHEDULE 13G | 0001213900-24-011378 | 005-91725 | 24607250 | 34 | 168361 | |||
| 2024-02-07 | SC 13G/A | calc13g020724.htm | 0001616824-24-000023 | 005-91725 | 24602916 | 34 | 79204 | |||
| 2024-02-07 | CORRESP | filename1.htm | 0001193125-24-025896 | 7563 | ||||||
| 2024-02-06 | 4 | xslF345X05/form4-02062024_100209.xml | 0001415889-24-002832 | 15450 | ||||||
| 2024-02-06 | UPLOAD | filename1.pdf | 0000000000-24-001432 | 333-276793 | 40605 | |||||
| 2024-02-05 | SC 13D/A | AMENDMENT NO. 4 | 0000947871-24-000092 | 005-91725 | 24596470 | 34 | 93788 | |||
| 2024-02-01 | SC 13G | e619220_sc13g-calcimedica.htm | 0001193805-24-000118 | 005-91725 | 24588033 | 34 | 106476 | |||
| 2024-02-01 | SC 13G | SCHEDULE 13G | 0001213900-24-008994 | 005-91725 | 24587103 | 34 | 142674 | |||
| 2024-01-31 | S-3 | S-3 | 0001193125-24-021064 | 333-276793 | 24583899 | 33 | 1070982 | |||
| 2024-01-31 | SC 13G | calc13g.htm | 0000935836-24-000078 | 005-91725 | 24583314 | 34 | 60337 | |||
| 2024-01-26 | SC 13G | SCHEDULE 13G | 0001213900-24-006981 | 005-91725 | 24567913 | 34 | 110521 | |||
| 2024-01-25 | 4 | xslF345X05/form4-01252024_080106.xml | 0001415889-24-001831 | 51302 | ||||||
| 2024-01-25 | 4 | xslF345X05/form4-01252024_080106.xml | 0001415889-24-001830 | 57919 | ||||||
| 2024-01-25 | 4 | xslF345X05/form4-01252024_080101.xml | 0001415889-24-001828 | 13962 | ||||||
| 2024-01-25 | 4 | xslF345X05/form4-01252024_080102.xml | 0001415889-24-001829 | 10445 | ||||||
| 2024-01-24 | 8-K/A | 8-K/A | 1.01,2.02,3.02,7.01,8.01,9.01 | 0001193125-24-013513 | 001-39538 | 24554170 | 34 | 1062633 | 1 | 1 |
| 2024-01-22 | 8-K | 8-K | 1.01,2.02,3.02,7.01,8.01,9.01 | 0001193125-24-011738 | 001-39538 | 24547176 | 34 | 1053130 | 1 | 1 |
| 2023-12-13 | 4 | FORM 4 SUBMISSION | 0001209191-23-058568 | 4781 | ||||||
| 2023-11-22 | SC 13D/A | SC 13D/A | 0001193125-23-282278 | 005-91725 | 231433927 | 34 | 139603 | |||
| 2023-11-09 | 10-Q | 10-Q | 0000950170-23-062176 | 001-39538 | 231393371 | 34 | 9689152 | 1 | 1 | |
| 2023-11-09 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-061514 | 001-39538 | 231390013 | 34 | 423877 | 1 | 1 |
| 2023-11-08 | 4 | FORM 4 SUBMISSION | 0001209191-23-054770 | 8743 | ||||||
| 2023-11-08 | 4 | FORM 4 SUBMISSION | 0001209191-23-054769 | 9843 | ||||||
| 2023-11-07 | 4 | FORM 4 SUBMISSION | 0001209191-23-054635 | 11579 | ||||||
| 2023-11-07 | 4 | FORM 4 SUBMISSION | 0001209191-23-054633 | 8747 | ||||||
| 2023-11-07 | 4 | FORM 4 SUBMISSION | 0001209191-23-054632 | 5254 | ||||||
| 2023-11-06 | 4 | FORM 4 SUBMISSION | 0001209191-23-054578 | 11585 | ||||||
| 2023-11-06 | 4 | FORM 4 SUBMISSION | 0001209191-23-054577 | 8354 | ||||||
| 2023-11-02 | 8-K | 8-K | 2.02,8.01,9.01 | 0001193125-23-268948 | 001-39538 | 231370412 | 34 | 196397 | 1 | 1 |
| 2023-10-10 | 4 | FORM 4 SUBMISSION | 0001209191-23-052521 | 73511 | ||||||
| 2023-10-10 | 3 | FORM 3 SUBMISSION | 0001209191-23-052515 | 16969 | ||||||
| 2023-09-05 | 4/A | FORM 4/A SUBMISSION | 0001209191-23-048235 | 5257 | ||||||
| 2023-08-29 | 4 | FORM 4 SUBMISSION | 0001209191-23-047674 | 9842 | ||||||
| 2023-08-23 | 4 | FORM 4 SUBMISSION | 0001209191-23-047106 | 12299 | ||||||
| 2023-08-18 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2023-08-18 16:00:00 | 9999999995-23-002449 | 333-273949 | 231187157 | 33 | 1998 | ||
| 2023-08-16 | CORRESP | filename1.htm | 0001193125-23-214310 | 7156 | ||||||
| 2023-08-15 | UPLOAD | filename1.pdf | 0000000000-23-008883 | 40480 | ||||||
| 2023-08-11 | S-3 | S-3 | 0001193125-23-210902 | 333-273949 | 231165105 | 33 | 1346753 | |||
| 2023-08-11 | 8-K | 8-K | 8.01,9.01 | 0001193125-23-210794 | 001-39538 | 231164518 | 34 | 2966441 | 1 | 1 |
| 2023-08-11 | 10-Q | 10-Q | 0000950170-23-041844 | 001-39538 | 231164070 | 34 | 9288840 | 1 | 1 | |
| 2023-08-10 | 8-K | 8-K | 2.02,5.07,9.01 | 0001193125-23-209160 | 001-39538 | 231160509 | 34 | 249161 | 1 | 1 |
| 2023-06-28 | 4 | FORM 4 SUBMISSION | 0001209191-23-040098 | 5608 | ||||||
| 2023-06-28 | 4 | FORM 4 SUBMISSION | 0001209191-23-040097 | 5597 | ||||||
| 2023-06-28 | 4 | FORM 4 SUBMISSION | 0001209191-23-040096 | 5606 | ||||||
| 2023-06-28 | 4 | FORM 4 SUBMISSION | 0001209191-23-040095 | 5575 | ||||||
| 2023-06-28 | ARS | ARS | 0000950170-23-030404 | 001-39538 | 231052435 | 34 | 2188349 | |||
| 2023-06-28 | DEFA14A | DEFA14A | 0000950170-23-030398 | 001-39538 | 231052286 | 34 | 2291639 | |||
| 2023-06-28 | DEF 14A | DEF 14A | 0000950170-23-030390 | 001-39538 | 231052205 | 34 | 2324530 | |||
| 2023-06-27 | 8-K | 8-K | 5.08 | 0001193125-23-176143 | 001-39538 | 231047323 | 34 | 150059 | 1 | 1 |
| 2023-06-26 | 4 | FORM 4 SUBMISSION | 0001209191-23-039831 | 12887 | ||||||
| 2023-06-22 | 4 | FORM 4 SUBMISSION | 0001209191-23-039176 | 11930 | ||||||
| 2023-06-15 | 4/A | FORM 4/A SUBMISSION | 0001209191-23-037586 | 5591 | ||||||
| 2023-06-15 | 8-K | 8-K | 7.01,9.01 | 0001193125-23-167330 | 001-39538 | 231015903 | 34 | 11253114 | 1 | 1 |
| 2023-06-13 | CERT | 8A CERT | 0001354457-23-000393 | 001-39538 | 231012032 | 34 | 118420 | |||
| 2023-06-13 | 8-A12B | 8-A12B | 0001193125-23-166014 | 001-39538 | 231011247 | 34 | 13643 | |||
| 2023-06-12 | 8-K | 8-K | 7.01,9.01 | 0001193125-23-165409 | 001-39538 | 231008917 | 34 | 174214 | 1 | 1 |
| 2023-06-09 | 4 | FORM 4 SUBMISSION | 0001209191-23-036129 | 13782 | ||||||
| 2023-06-09 | 4 | FORM 4 SUBMISSION | 0001209191-23-036128 | 9841 | ||||||
| 2023-06-09 | 4 | FORM 4 SUBMISSION | 0001209191-23-036127 | 10266 | ||||||
| 2023-06-08 | 4 | FORM 4 SUBMISSION | 0001209191-23-035613 | 15306 | ||||||
| 2023-06-08 | 4 | FORM 4 SUBMISSION | 0001209191-23-035612 | 11976 | ||||||
| 2023-06-08 | 4 | FORM 4 SUBMISSION | 0001209191-23-035609 | 10662 | ||||||
| 2023-06-05 | 4 | FORM 4 SUBMISSION | 0001209191-23-034646 | 8352 | ||||||
| 2023-06-05 | 4/A | FORM 4/A SUBMISSION | 0001209191-23-034642 | 5652 | ||||||
| 2023-06-05 | 4 | FORM 4 SUBMISSION | 0001209191-23-034639 | 12144 | ||||||
| 2023-06-01 | 4 | FORM 4 SUBMISSION | 0001209191-23-033461 | 8056 | ||||||
| 2023-06-01 | 4 | FORM 4 SUBMISSION | 0001209191-23-033460 | 7787 | ||||||
| 2023-06-01 | 4 | FORM 4 SUBMISSION | 0001209191-23-033459 | 9841 | ||||||
| 2023-05-24 | 4 | FORM 4 SUBMISSION | 0001209191-23-032025 | 4746 | ||||||
| 2023-05-24 | 4 | FORM 4 SUBMISSION | 0001209191-23-032024 | 8060 | ||||||
| 2023-05-24 | 4 | FORM 4 SUBMISSION | 0001209191-23-032023 | 11186 | ||||||
| 2023-05-23 | SC 13D/A | e618664_sc13da-calcimedica.htm | 0001193805-23-000782 | 005-91725 | 23949931 | 34 | 170127 | |||
| 2023-05-22 | 4 | FORM 4 SUBMISSION | 0001209191-23-031472 | 6264 | ||||||
| 2023-05-22 | 4 | FORM 4 SUBMISSION | 0001209191-23-031382 | 13783 | ||||||
| 2023-05-18 | 4 | FORM 4 SUBMISSION | 0001209191-23-030782 | 11222 | ||||||
| 2023-05-18 | 4 | FORM 4 SUBMISSION | 0001209191-23-030780 | 5252 | ||||||
| 2023-05-18 | 4 | FORM 4 SUBMISSION | 0001209191-23-030779 | 12352 | ||||||
| 2023-05-18 | 4 | FORM 4 SUBMISSION | 0001209191-23-030778 | 7667 | ||||||
| 2023-05-15 | 8-K | 8-K | 2.02,9.01 | 0001193125-23-144226 | 001-39538 | 23918567 | 34 | 225261 | 1 | 1 |
| 2023-05-12 | S-8 | S-8 | 0001193125-23-143616 | 333-271898 | 23916931 | 33 | 106724 | |||
| 2023-05-12 | 10-Q | 10-Q | 0000950170-23-021775 | 001-39538 | 23915885 | 34 | 9109920 | 1 | 1 | |
| 2023-05-12 | 8-K/A | 8-K/A | 9.01 | 0001193125-23-143469 | 001-39538 | 23915690 | 34 | 795809 | 1 | 1 |
| 2023-05-12 | 8-K | 8-K | 4.02 | 0001193125-23-143456 | 001-39538 | 23915482 | 34 | 154963 | 1 | 1 |
| 2023-05-10 | 4 | FORM 4 SUBMISSION | 0001209191-23-028552 | 5679 | ||||||
| 2023-05-10 | 4 | FORM 4 SUBMISSION | 0001209191-23-028551 | 5678 | ||||||
| 2023-05-10 | 4 | FORM 4 SUBMISSION | 0001209191-23-028550 | 5672 | ||||||
| 2023-05-10 | 4 | FORM 4 SUBMISSION | 0001209191-23-028547 | 5687 | ||||||
| 2023-05-10 | 4 | FORM 4 SUBMISSION | 0001209191-23-028546 | 5704 | ||||||
| 2023-05-05 | 8-K | 8-K | 3.01,8.01 | 0001193125-23-137097 | 001-39538 | 23893882 | 34 | 156528 | 1 | 1 |
| 2023-05-03 | 4 | FORM 4 SUBMISSION | 0001209191-23-027199 | 9304 | ||||||
| 2023-05-03 | 3 | FORM 3 SUBMISSION | 0001209191-23-027198 | 7554 | ||||||
| 2023-05-03 | 4 | FORM 4 SUBMISSION | 0001209191-23-027196 | 17525 | ||||||
| 2023-05-03 | 3 | FORM 3 SUBMISSION | 0001209191-23-027193 | 6570 | ||||||
| 2023-04-14 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2023-04-14 16:00:00 | 9999999995-23-000946 | 333-271115 | 23822712 | 33 | 1997 | ||
| 2023-04-12 | CORRESP | filename1.htm | 0001193125-23-099209 | 7141 | ||||||
| 2023-04-10 | UPLOAD | filename1.pdf | 0000000000-23-003564 | 40535 | ||||||
| 2023-04-04 | S-3 | S-3 | 0001193125-23-090982 | 333-271115 | 23798815 | 33 | 384773 | |||
| 2023-04-04 | 8-K/A | 8-K/A | 9.01 | 0001193125-23-090853 | 001-39538 | 23797418 | 34 | 757227 | 1 | 1 |
| 2023-04-04 | 10-K/A | 10-K/A | 0001193125-23-090842 | 001-39538 | 23797238 | 34 | 649668 | 1 | 1 | |
| 2023-04-04 | D | xslFormDX01/primary_doc.xml | 06b | 0001921043-23-000002 | 021-477891 | 23796742 | 33 | 15342 | ||
| 2023-03-30 | SC 13D | SC 13D | 0001193125-23-085803 | 005-91725 | 23781978 | 34 | 143594 | |||
| 2023-03-30 | SC 13G | SC 13G | 0001193125-23-085503 | 005-91725 | 23780558 | 34 | 119272 | |||
| 2023-03-28 | SC 13D/A | e618407_sc13da-calcimedica.htm | 0001193805-23-000396 | 005-91725 | 23766552 | 34 | 133027 | |||
| 2023-03-27 | 4 | FORM 4 SUBMISSION | 0001209191-23-021307 | 9963 | ||||||
| 2023-03-27 | 4 | FORM 4 SUBMISSION | 0001209191-23-021306 | 8121 | ||||||
| 2023-03-27 | 4 | FORM 4 SUBMISSION | 0001209191-23-021305 | 8099 | ||||||
| 2023-03-27 | 4 | FORM 4 SUBMISSION | 0001209191-23-021303 | 9777 | ||||||
| 2023-03-27 | 4 | FORM 4 SUBMISSION | 0001209191-23-021301 | 8124 | ||||||
| 2023-03-27 | 4 | FORM 4 SUBMISSION | 0001209191-23-021300 | 9642 | ||||||
| 2023-03-27 | 4 | FORM 4 SUBMISSION | 0001209191-23-021298 | 8060 | ||||||
| 2023-03-27 | 4 | FORM 4 SUBMISSION | 0001209191-23-021297 | 8107 | ||||||
| 2023-03-27 | SC 13D/A | e618404_sc13da-calcimedica.htm | 0001193805-23-000392 | 005-91725 | 23764641 | 34 | 151699 | |||
| 2023-03-24 | SC 13D/A | AMENDMENT NO. 3 | 0000947871-23-000381 | 005-91725 | 23760575 | 34 | 91492 | |||
| 2023-03-22 | 4 | FORM 4 SUBMISSION | 0001209191-23-020684 | 67212 | ||||||
| 2023-03-22 | 4 | FORM 4 SUBMISSION | 0001209191-23-020683 | 9317 | ||||||
| 2023-03-22 | 4 | FORM 4 SUBMISSION | 0001209191-23-020682 | 22805 | ||||||
| 2023-03-22 | 4 | FORM 4 SUBMISSION | 0001209191-23-020680 | 49234 | ||||||
| 2023-03-22 | 4 | FORM 4 SUBMISSION | 0001209191-23-020679 | 35174 | ||||||
| 2023-03-22 | 4 | FORM 4 SUBMISSION | 0001209191-23-020678 | 43458 | ||||||
| 2023-03-22 | 4 | FORM 4 SUBMISSION | 0001209191-23-020677 | 31263 | ||||||
| 2023-03-22 | 4 | FORM 4 SUBMISSION | 0001209191-23-020676 | 44655 | ||||||
| 2023-03-22 | 3 | FORM 3 SUBMISSION | 0001209191-23-020672 | 6197 | ||||||
| 2023-03-22 | 3 | FORM 3 SUBMISSION | 0001209191-23-020671 | 6198 | ||||||
| 2023-03-22 | 3 | FORM 3 SUBMISSION | 0001209191-23-020670 | 6205 | ||||||
| 2023-03-22 | 3 | FORM 3 SUBMISSION | 0001209191-23-020668 | 6281 | ||||||
| 2023-03-22 | 3 | FORM 3 SUBMISSION | 0001209191-23-020666 | 6295 | ||||||
| 2023-03-22 | 3 | FORM 3 SUBMISSION | 0001209191-23-020665 | 6281 | ||||||
| 2023-03-22 | 3 | FORM 3 SUBMISSION | 0001209191-23-020664 | 6261 | ||||||
| 2023-03-22 | 3 | FORM 3 SUBMISSION | 0001209191-23-020663 | 6278 | ||||||
| 2023-03-22 | 8-K | 8-K | 2.01,3.01,3.02,3.03,5.01,5.02,5.03,8.01,9.01 | 0001193125-23-076714 | 001-39538 | 23753149 | 34 | 2990376 | 1 | 1 |
| 2023-03-15 | 8-K | 8-K | 5.07,8.01 | 0001193125-23-071452 | 001-39538 | 23736052 | 34 | 172536 | 1 | 1 |
| 2023-03-15 | 4 | FORM 4 SUBMISSION | 0001209191-23-018885 | 9102 | ||||||
| 2023-03-09 | 10-K | 10-K | 0000950170-23-006795 | 001-39538 | 23717934 | 34 | 11999777 | 1 | 1 | |
| 2023-03-06 | 4 | FORM 4 SUBMISSION | 0001209191-23-016514 | 14027 | ||||||
| 2023-03-06 | 4 | FORM 4 SUBMISSION | 0001209191-23-016513 | 14001 | ||||||
| 2023-03-06 | 4 | FORM 4 SUBMISSION | 0001209191-23-016509 | 13988 | ||||||
| 2023-03-03 | DEFA14A | DEFA14A | 0001193125-23-060023 | 001-39538 | 23703954 | 34 | 74626 | |||
| 2023-03-03 | 8-K | 8-K | 5.02,8.01 | 0001193125-23-059999 | 001-39538 | 23703768 | 34 | 235551 | 1 | 1 |
| 2023-02-16 | DEFA14A | DEFA14A | 0001193125-23-041106 | 001-39538 | 23638852 | 34 | 92497 | |||
| 2023-02-16 | 8-K | 8-K | 1.01,9.01 | 0001193125-23-041092 | 001-39538 | 23638816 | 34 | 246090 | 1 | 1 |
| 2023-02-13 | SC 13G/A | SC 13G/A | 0001104659-23-019065 | 005-91725 | 23614839 | 34 | 391833 | |||
| 2023-02-10 | UPLOAD | filename1.pdf | 0000000000-23-001410 | 39989 | ||||||
| 2023-02-09 | DEFM14A | DEFM14A | 0001193125-23-030343 | 001-39538 | 23607311 | 34 | 14700969 | |||
| 2023-02-09 | 8-K | 8-K | 5.02,9.01 | 0001193125-23-030003 | 001-39538 | 23606220 | 34 | 189613 | 1 | 1 |
| 2023-02-08 | SC 13G/A | NONE | 0001567619-23-002102 | 005-91725 | 23599993 | 34 | 66959 | |||
| 2023-02-06 | CORRESP | filename1.htm | 0001193125-23-024831 | 25344 | ||||||
| 2023-02-06 | PRER14A | PRER14A | 0001193125-23-024800 | 001-39538 | 23588285 | 34 | 10775082 | |||
| 2023-02-03 | UPLOAD | filename1.pdf | 0000000000-23-001151 | 45346 | ||||||
| 2023-01-31 | CORRESP | filename1.htm | 0001193125-23-020420 | 45126 | ||||||
| 2023-01-31 | PRER14A | PRER14A | 0001193125-23-020415 | 001-39538 | 23573063 | 34 | 10742402 | |||
| 2023-01-27 | UPLOAD | filename1.pdf | 0000000000-23-000929 | 52035 | ||||||
| 2023-01-20 | CORRESP | filename1.htm | 0001193125-23-012047 | 60871 | ||||||
| 2023-01-20 | PRER14A | PRER14A | 0001193125-23-012044 | 001-39538 | 23541348 | 34 | 10719777 | |||
| 2023-01-11 | UPLOAD | filename1.pdf | 0000000000-23-000296 | 63985 | ||||||
| 2022-12-28 | 8-K | 8-K | 3.01 | 0001193125-22-313722 | 001-39538 | 221494433 | 34 | 149618 | 1 | 1 |
| 2022-12-14 | PREM14A | PREM14A | 0001193125-22-304920 | 001-39538 | 221462992 | 34 | 10698738 | |||
| 2022-12-14 | 4 | FORM 4 SUBMISSION | 0001209191-22-061177 | 9034 | ||||||
| 2022-12-01 | 4 | FORM 4 SUBMISSION | 0001209191-22-059207 | 9060 | ||||||
| 2022-12-01 | 4 | FORM 4 SUBMISSION | 0001209191-22-059206 | 9099 | ||||||
| 2022-12-01 | 4 | FORM 4 SUBMISSION | 0001209191-22-059205 | 9075 | ||||||
| 2022-12-01 | SC 13G | NONE | 0001567619-22-021110 | 005-91725 | 221438723 | 34 | 66971 | |||
| 2022-11-29 | 4 | FORM 4 SUBMISSION | 0001209191-22-058951 | 9045 | ||||||
| 2022-11-29 | 4 | FORM 4 SUBMISSION | 0001209191-22-058950 | 9123 | ||||||
| 2022-11-29 | 4 | FORM 4 SUBMISSION | 0001209191-22-058949 | 9092 | ||||||
| 2022-11-23 | SC 13D/A | e618056_sc13da-graybug.htm | 0001193805-22-001604 | 005-91725 | 221415844 | 34 | 159167 |
One latest value per concept from companyfacts (269 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 6.90M | 2026-11-05 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 15.70M | 2025-06-30 | 2025 | FY | 10-K/A | 2026-04-30 | 0001193125-26-197104 | |
| ecd | NonPeoNeoAvgCompActuallyPaidAmt | NonPeoNeoAvgCompActuallyPaidAmt | USD | 1.67M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-07-23 | 0001193125-26-314085 | ||
| ecd | NonPeoNeoAvgTotalCompAmt | NonPeoNeoAvgTotalCompAmt | USD | 733,437 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-07-23 | 0001193125-26-314085 | ||
| ecd | PeoActuallyPaidCompAmt | PeoActuallyPaidCompAmt | USD | 2.44M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-07-23 | 0001193125-26-314085 | ||
| ecd | PeoTotalCompAmt | PeoTotalCompAmt | USD | 895,410 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-07-23 | 0001193125-26-314085 | ||
| ecd | TotalShareholderRtnAmt | TotalShareholderRtnAmt | USD | 230 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-07-23 | 0001193125-26-314085 | ||
| ffd | NetFeeAmt | NetFeeAmt | USD | 444.52 | 2026-09-22 | S-8 | 2026-09-23 | 0001193125-26-399649 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 444.52 | 2026-09-22 | S-8 | 2026-09-23 | 0001193125-26-399649 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 3.22M | 2026-09-22 | S-8 | 2026-09-23 | 0001193125-26-399649 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-09-22 | S-8 | 2026-09-23 | 0001193125-26-399649 | |||
| ffd | TtlPrevslyPdAmt | TtlPrevslyPdAmt | USD | 0 | 2026-07-21 | S-3 | 2026-07-24 | 0001193125-26-316100 | |||
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 1.02M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 | |
| us-gaap | AccountsPayableRelatedPartiesCurrent | Accounts Payable, Related Parties, Current | USD | 0 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-05 | 0001564590-21-011305 | |
| us-gaap | AccretionAmortizationOfDiscountsAndPremiumsInvestments | Accretion (Amortization) of Discounts and Premiums, Investments | USD | 61,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 200,000 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0000950170-23-006795 | |
| us-gaap | AccruedProfessionalFeesCurrent | Accrued Professional Fees, Current | USD | 685,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 | |
| us-gaap | AccruedRentCurrent | Accrued Rent, Current | USD | 13,300 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 1.65M | 2021-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0000950170-23-006795 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | -7,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 | |
| us-gaap | AdditionalPaidInCapitalCommonStock | Additional Paid in Capital, Common Stock | USD | 197.91M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 496,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalWarrantIssued | Adjustments to Additional Paid in Capital, Warrant Issued | USD | 216,000 | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-03-27 | 0000950170-25-046035 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 12.04M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-28 | 0000950170-24-038064 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 10.61M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 |
| us-gaap | AssetImpairmentCharges | Asset Impairment Charges | USD | 1.60M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0000950170-23-006795 |
| us-gaap | Assets | Assets | USD | 14.29M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 14.22M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 | |
| us-gaap | AssetsFairValueDisclosure | Assets, Fair Value Disclosure | USD | 34.20M | 2022-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0000950170-23-006795 | |
| us-gaap | AssetsHeldForSaleNotPartOfDisposalGroup | Assets Held-for-sale, Not Part of Disposal Group | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 | |
| us-gaap | AssetsHeldForSaleNotPartOfDisposalGroupCurrent | Assets Held-for-sale, Not Part of Disposal Group, Current | USD | 350,000 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-10 | 0001564590-22-037397 | |
| us-gaap | BusinessCombinationAcquisitionRelatedCosts | Business Combination, Acquisition Related Costs | USD | 10.50M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-27 | 0000950170-25-046035 |
| us-gaap | BusinessCombinationConsiderationTransferred1 | Business Combination, Consideration Transferred | USD | 29.40M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 |
| us-gaap | BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets | USD | 2.10M | 2024-12-31 | 2024 | FY | 10-K | 2025-03-27 | 0000950170-25-046035 | |
| us-gaap | BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable | USD | 2.30M | 2024-12-31 | 2024 | FY | 10-K | 2025-03-27 | 0000950170-25-046035 | |
| us-gaap | CapitalExpendituresIncurredButNotYetPaid | Capital Expenditures Incurred but Not yet Paid | USD | 115,000 | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0000950170-23-006795 |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 4.57M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 | |
| us-gaap | CashAndCashEquivalentsFairValueDisclosure | Cash and Cash Equivalents, Fair Value Disclosure | USD | 12.37M | 2022-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0000950170-23-006795 | |
| us-gaap | CashCashEquivalentsAndShortTermInvestments | Cash, Cash Equivalents, and Short-term Investments | USD | 13.80M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | USD | 4.57M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | -6.95M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 |
| us-gaap | CashEquivalentsAtCarryingValue | Cash Equivalents, at Carrying Value | USD | 0 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-28 | 0000950170-24-038064 | |
| us-gaap | ClassOfWarrantOrRightOutstanding | Class of Warrant or Right, Outstanding | shares | 8.36M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 | |
| us-gaap | CommonStockCapitalSharesReservedForFutureIssuance | Common Stock, Capital Shares Reserved for Future Issuance | shares | 11.08M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 100.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 6.89M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 6.89M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 1,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -4.36M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 |
| us-gaap | ContractualObligation | Contractual Obligation | USD | 9.10M | 2022-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0000950170-23-006795 | |
| us-gaap | ConversionOfStockAmountIssued1 | Conversion of Stock, Amount Issued | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-27 | 0000950170-25-046035 |
| us-gaap | ConvertibleNotesPayable | Convertible Notes Payable | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-28 | 0000950170-24-038064 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months | USD | 33.50M | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-10 | 0001564590-22-037397 | |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss | Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 | |
| us-gaap | DeferredIncomeTaxLiabilities | Deferred Tax Liabilities, Gross | USD | 11,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001193125-26-088147 | |
| us-gaap | DeferredRentCreditCurrent | Deferred Rent Credit, Current | USD | 8,000 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0000950170-23-006795 | |
| us-gaap | DeferredRentCreditNoncurrent | Deferred Rent Credit, Noncurrent | USD | 8,000 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0000950170-23-006795 | |
| us-gaap | DeferredTaxAssetsGoodwillAndIntangibleAssets | Deferred Tax Assets, Goodwill and Intangible Assets | USD | 10.54M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001193125-26-088147 | |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 92.66M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001193125-26-088147 | |
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001193125-26-088147 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 66.33M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001193125-26-088147 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwardsDomestic | Deferred Tax Assets, Operating Loss Carryforwards, Domestic | USD | 315.40M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001193125-26-088147 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal | Deferred Tax Assets, Operating Loss Carryforwards, State and Local | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-27 | 0000950170-25-046035 | |
| us-gaap | DeferredTaxAssetsOther | Deferred Tax Assets, Other | USD | 1.70M | 2023-12-31 | 2023 | FY | 10-K | 2024-03-28 | 0000950170-24-038064 | |
| us-gaap | DeferredTaxAssetsStateTaxes | Deferred Tax Assets, State Taxes | USD | 9.87M | 2023-12-31 | 2023 | FY | 10-K | 2024-03-28 | 0000950170-24-038064 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwards | Deferred Tax Assets, Tax Credit Carryforwards | USD | 14.33M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001193125-26-088147 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwardsResearch | Deferred Tax Assets, Tax Credit Carryforwards, Research | USD | 12.40M | 2023-12-31 | 2023 | FY | 10-K | 2024-03-28 | 0000950170-24-038064 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | USD | 1.39M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001193125-26-088147 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals | USD | 93,000 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-28 | 0000950170-24-038064 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 92.65M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001193125-26-088147 | |
| us-gaap | DeferredTaxLiabilitiesPropertyPlantAndEquipment | Deferred Tax Liabilities, Property, Plant and Equipment | USD | 11,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001193125-26-088147 | |
| us-gaap | DefinedContributionPlanEmployerDiscretionaryContributionAmount | Defined Contribution Plan, Employer Discretionary Contribution Amount | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 |
| us-gaap | DepositsAssetsNoncurrent | Deposits Assets, Noncurrent | USD | 608,000 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-05 | 0001564590-21-011305 | |
| us-gaap | Depreciation | Depreciation | USD | 21,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 |
| us-gaap | DepreciationDepletionAndAmortization | Depreciation, Depletion and Amortization | USD | 58,000 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-28 | 0000950170-24-038064 |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -0.96 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | -0.48 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-12 | 0001564590-22-019611 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -0.96 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0000950170-23-006795 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.149 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0000950170-23-006795 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent | pure | -0.053 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0000950170-23-006795 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | -0.025 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0000950170-23-006795 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent | pure | 0.017 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0000950170-23-006795 |
| us-gaap | EmployeeRelatedLiabilitiesCurrent | Employee-related Liabilities, Current | USD | 758,000 | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-12 | 0000950170-23-021775 | |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | USD | 11.50M | 2022-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0000950170-23-006795 | |
| us-gaap | FairValueAdjustmentOfWarrants | Fair Value Adjustment of Warrants | USD | -7.70M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 |
| us-gaap | FairValueAssetsLevel1ToLevel2TransfersAmount | Fair Value, Assets, Level 1 to Level 2 Transfers, Amount | USD | 0 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-12 | 0001564590-22-019611 | |
| us-gaap | FairValueAssetsLevel2ToLevel1TransfersAmount | Fair Value, Assets, Level 2 to Level 1 Transfers, Amount | USD | 0 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-12 | 0001564590-22-019611 | |
| us-gaap | FairValueLiabilitiesLevel1ToLevel2TransfersAmount | Fair Value, Liabilities, Level 1 to Level 2 Transfers, Amount | USD | 0 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-12 | 0001564590-22-019611 | |
| us-gaap | FairValueLiabilitiesLevel2ToLevel1TransfersAmount | Fair Value, Liabilities, Level 2 to Level 1 Transfers, Amount | USD | 0 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-12 | 0001564590-22-019611 | |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3 | Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3 | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0000950170-23-006795 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3 | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3 | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0000950170-23-006795 |
| us-gaap | FairValueNetAssetLiability | Fair Value, Net Asset (Liability) | USD | 300,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 | |
| us-gaap | GainLossOnDispositionOfAssets1 | Gain (Loss) on Disposition of Assets | USD | -97,000 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0000950170-23-006795 |
| us-gaap | GainLossOnSaleOfPropertyPlantEquipment | Gain (Loss) on Disposition of Property Plant Equipment | USD | 31,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 6.47M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 |
| us-gaap | ImpairmentOfLongLivedAssetsHeldForUse | Impairment of Long-Lived Assets Held-for-use | USD | 0 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-13 | 0000950170-24-126296 |
| us-gaap | ImpairmentOfLongLivedAssetsToBeDisposedOf | Impairment of Long-Lived Assets to be Disposed of | USD | 1.31M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0000950170-23-006795 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic | Income (Loss) from Continuing Operations before Income Taxes, Domestic | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001193125-26-088147 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | -29.56M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001193125-26-088147 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign | Income (Loss) from Continuing Operations before Income Taxes, Foreign | USD | -29.56M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001193125-26-088147 |
| us-gaap | IncomeTaxesPaidNet | Income Taxes Paid, Net | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001193125-26-088147 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 5.47M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001193125-26-088147 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -2.88M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001193125-26-088147 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount | USD | 705,000 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-28 | 0000950170-24-038064 |
| us-gaap | IncomeTaxReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount | USD | 611,000 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001193125-26-088147 |
| us-gaap | IncomeTaxReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount | USD | -1.05M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001193125-26-088147 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | -441,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 |
| us-gaap | IncreaseDecreaseInAccruedLiabilities | Increase (Decrease) in Accrued Liabilities | USD | -104,000 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0000950170-23-006795 |
| us-gaap | IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities | USD | 410,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 |
| us-gaap | IncreaseDecreaseInDeferredCharges | Increase (Decrease) in Deferred Charges | USD | -1,000 | 2021-01-01 | 2021-09-30 | 2022 | Q3 | 10-Q | 2022-11-10 | 0001564590-22-037397 |
| us-gaap | IncreaseDecreaseInOperatingLeaseLiability | IncreaseDecreaseInOperatingLeaseLiability | USD | -380,000 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0000950170-23-006795 |
| us-gaap | IncreaseDecreaseInOtherCurrentLiabilities | Increase (Decrease) in Other Current Liabilities | USD | -747,000 | 2020-01-01 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-12 | 0001564590-20-053539 |
| us-gaap | IncreaseDecreaseInOtherOperatingLiabilities | Increase (Decrease) in Other Operating Liabilities | USD | -1.89M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0000950170-23-006795 |
| us-gaap | IncrementalCommonSharesAttributableToShareBasedPaymentArrangements | Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements | shares | 479,284 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-12 | 0001193125-26-219426 |
| us-gaap | InterestExpenseNonoperating | InterestExpenseNonoperating | USD | 1.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 |
| us-gaap | InterestPaidNet | Interest Paid, Excluding Capitalized Interest, Operating Activities | USD | 1.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 |
| us-gaap | InvestmentIncomeInterest | Investment Income, Interest | USD | 575,000 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0000950170-23-006795 |
| us-gaap | IssuanceOfStockAndWarrantsForServicesOrClaims | Issuance of Stock and Warrants for Services or Claims | USD | 8,000 | 2022-01-01 | 2022-09-30 | 2023 | Q3 | 10-Q | 2023-11-09 | 0000950170-23-062176 |
| us-gaap | LeaseAndRentalExpense | Operating Leases, Rent Expense | USD | 30,000 | 2024-01-01 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-13 | 0000950170-24-058744 |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 118,000 | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-12 | 0000950170-23-021775 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 70,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001193125-26-088147 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 103,000 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-10 | 0001564590-22-037397 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 1,000 | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-12 | 0000950170-23-021775 | |
| us-gaap | Liabilities | Liabilities | USD | 10.07M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 14.29M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 2.87M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 | |
| us-gaap | LiabilitiesFairValueDisclosure | Financial and Nonfinancial Liabilities, Fair Value Disclosure | USD | 0 | 2023-12-31 | 2024 | FY | 10-K | 2025-03-27 | 0000950170-25-046035 | |
| us-gaap | LineOfCreditFacilityMaximumBorrowingCapacity | Line of Credit Facility, Maximum Borrowing Capacity | USD | 10.00M | 2026-06-23 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 | |
| us-gaap | LongTermInvestments | Long-term Investments | USD | 4.63M | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-12 | 0001564590-21-044001 | |
| us-gaap | LossContingencyDamagesSoughtValue | Loss Contingency, Damages Sought, Value | USD | 1.50M | 2025-04-11 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 13.99M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | -7.60M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -13.34M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -4.35M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersBasic | Net Income (Loss) Available to Common Stockholders, Basic | USD | -4.35M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 |
| us-gaap | NetRentableArea | Net Rentable Area | sqft | 691 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 | |
| us-gaap | NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 | Noncash or Part Noncash Acquisition, Fixed Assets Acquired | USD | 334,000 | 2025-01-01 | 2025-03-31 | 2025 | Q1 | 10-Q | 2025-05-14 | 0000950170-25-071421 |
| us-gaap | NoninterestIncome | Noninterest Income | USD | 294,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | 10.02M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 14.37M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -14.37M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 |
| us-gaap | OperatingLeaseExpense | Operating Lease, Expense | USD | 500,000 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0000950170-23-006795 |
| us-gaap | OperatingLeaseImpairmentLoss | Operating Lease, Impairment Loss | USD | 290,000 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0000950170-23-006795 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 117,000 | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-12 | 0000950170-23-021775 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 203,000 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0000950170-23-006795 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 102,000 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-12 | 0001564590-22-019611 | |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-28 | 0000950170-24-038064 | |
| us-gaap | OperatingLeaseRightOfUseAssetAmortizationExpense | Operating Lease, Right-of-Use Asset, Amortization Expense | USD | 277,000 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0000950170-23-006795 |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDue | Operating Leases, Future Minimum Payments Due | USD | 732,000 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0000950170-23-006795 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueCurrent | Operating Leases, Future Minimum Payments Due, Next Twelve Months | USD | 118,000 | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-12 | 0000950170-23-021775 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInThreeYears | Operating Leases, Future Minimum Payments, Due in Three Years | USD | 205,000 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-05 | 0001564590-21-011305 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInTwoYears | Operating Leases, Future Minimum Payments, Due in Two Years | USD | 205,000 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0000950170-23-006795 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear | Operating Leases, Future Minimum Payments, Remainder of Fiscal Year | USD | 146,000 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-12 | 0001564590-21-056418 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 1.62M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 | |
| us-gaap | OtherAssets | Other Assets | USD | 4,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 | |
| us-gaap | OtherAssetsCurrent | Other Assets, Current | USD | 1.35M | 2021-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0000950170-23-006795 | |
| us-gaap | OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent | Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent | USD | -7,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 |
| us-gaap | OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax | USD | -6,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 |
| us-gaap | OtherLiabilitiesCurrent | Other Liabilities, Current | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-28 | 0000950170-24-038064 | |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | 231,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 |
| us-gaap | OtherRestructuringCosts | Other Restructuring Costs | USD | 299,000 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0000950170-23-006795 |
| us-gaap | OtherSundryLiabilitiesCurrent | Other Sundry Liabilities, Current | USD | 77,000 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0000950170-23-006795 | |
| us-gaap | OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings | Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale, Recognized in Earnings | USD | 0 | 2024-01-01 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-13 | 0000950170-24-058744 |
| us-gaap | PaymentsOfMergerRelatedCostsFinancingActivities | Payments of Merger Related Costs, Financing Activities | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-27 | 0000950170-25-046035 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 |
| us-gaap | PaymentsRelatedToTaxWithholdingForShareBasedCompensation | Payment, Tax Withholding, Share-based Payment Arrangement | USD | 139,000 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0000950170-23-006795 |
| us-gaap | PaymentsToAcquireInProcessResearchAndDevelopment | Payments to Acquire in Process Research and Development | USD | 1.94M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0000950170-23-006795 |
| us-gaap | PaymentsToAcquireInvestments | Payments to Acquire Investments | USD | 9.14M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 |
| us-gaap | PaymentsToAcquireShortTermInvestments | Payments to Acquire Short-term Investments | USD | 21.52M | 2021-01-01 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-14 | 0001564590-21-028030 |
| us-gaap | PreferredStockDividendsIncomeStatementImpact | Preferred Stock Dividends, Income Statement Impact | USD | 7.19M | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-11 | 0001564590-22-009728 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 10.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 432,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 | |
| us-gaap | PrepaidExpenseAndOtherAssetsNoncurrent | Prepaid Expense and Other Assets, Noncurrent | USD | 29,000 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0000950170-23-006795 | |
| us-gaap | PrepaidExpenseCurrent | Prepaid Expense, Current | USD | 503,000 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0000950170-23-006795 | |
| us-gaap | ProceedsFromConvertibleDebt | Proceeds from Convertible Debt | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 10.20M | 2024-11-01 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 | |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 11.17M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 |
| us-gaap | ProceedsFromIssuanceOfConvertiblePreferredStock | Proceeds from Issuance of Convertible Preferred Stock | USD | 54.78M | 2019-01-01 | 2019-12-31 | 2020 | FY | 10-K | 2021-03-05 | 0001564590-21-011305 |
| us-gaap | ProceedsFromIssuanceOfWarrants | Proceeds from Issuance of Warrants | USD | 2.79M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 |
| us-gaap | ProceedsFromOtherEquity | Proceeds from Other Equity | USD | 31,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 |
| us-gaap | ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments | Proceeds from Sale, Maturity and Collection of Short-term Investments | USD | 8.00M | 2021-01-01 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-14 | 0001564590-21-028030 |
| us-gaap | ProceedsFromSaleMaturityAndCollectionsOfInvestments | Proceeds from Sale, Maturity and Collection of Investments | USD | 1.50M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 |
| us-gaap | ProceedsFromSaleOfPropertyPlantAndEquipment | Proceeds from Sale of Property, Plant, and Equipment | USD | 42,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -4.35M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 3.63M | 2021-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0000950170-23-006795 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 72,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 | |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 7.91M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 |
| us-gaap | ResearchAndDevelopmentInProcess | Research and Development in Process | USD | 2.19M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0000950170-23-006795 |
| us-gaap | RestrictedCash | Restricted Cash | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-28 | 0000950170-24-038064 | |
| us-gaap | RestructuringAndRelatedCostNumberOfPositionsEliminated | Restructuring and Related Cost, Number of Positions Eliminated | Employee | 20 | 2022-09-01 | 2022-10-31 | 2022 | FY | 10-K | 2023-03-09 | 0000950170-23-006795 |
| us-gaap | RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent | Restructuring and Related Cost, Number of Positions Eliminated, Period Percent | pure | 0.71 | 2022-08-18 | 2022 | FY | 10-K | 2023-03-09 | 0000950170-23-006795 | |
| us-gaap | RestructuringCharges | Restructuring Charges | USD | 3.00M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0000950170-23-006795 |
| us-gaap | RestructuringSettlementAndImpairmentProvisions | Restructuring, Settlement and Impairment Provisions | USD | 2.96M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0000950170-23-006795 |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -193.68M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 | |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 567,000 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0000950170-23-006795 |
| us-gaap | SeveranceCosts1 | Severance Costs | USD | 5.70M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-27 | 0000950170-25-046035 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 1.60M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost | Share-based Payment Arrangement, Accelerated Cost | USD | 128.00M | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-05 | 0001564590-21-011305 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Accelerated Vesting, Number | shares | 61,812 | 2019-01-01 | 2019-12-31 | 2020 | FY | 10-K | 2021-03-05 | 0001564590-21-011305 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1 | Share-based Payment Arrangement, Expensed and Capitalized, Amount | USD | 1.60M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 0 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-12 | 0001193125-26-219426 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number | shares | 4,500 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | pure | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | pure | 1.21 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum | pure | 0.88 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0000950170-23-006795 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum | pure | 0.87 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0000950170-23-006795 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | pure | 0.043 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum | pure | 0.029 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0000950170-23-006795 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum | pure | 0.016 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0000950170-23-006795 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | USD | 41.97M | 2021-12-31 | 2021 | FY | 10-K | 2022-03-11 | 0001564590-22-009728 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | shares | 2.40M | 2022-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0000950170-23-006795 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | USD/shares | 5.87 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0000950170-23-006795 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0000950170-23-006795 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | shares | 56,237 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 1.35M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 0.96 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0000950170-23-006795 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | USD | 15.94M | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 2.26M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Period Increase (Decrease), Weighted Average Exercise Price | USD/shares | 76.72 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-28 | 0000950170-24-038064 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 9.16 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value | USD | 14,000 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-11 | 0001193125-26-344689 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number | shares | 682,312 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price | USD/shares | 21.75 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value | USD | 4.00M | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-11 | 0001564590-22-009728 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value | USD/shares | 6.06 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-11 | 0001564590-22-009728 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | USD/shares | 10.28 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 1.89 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 |
| us-gaap | ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate | Share-based Goods and Nonemployee Services Transaction, Valuation Method, Expected Dividend Rate | pure | 0 | 2024-01-01 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-13 | 0000950170-24-058744 |
| us-gaap | ShortTermInvestments | Short-term Investments | USD | 9.19M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 | |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 4.23M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 | |
| us-gaap | StockholdersEquityNoteStockSplitConversionRatio1 | Stockholders' Equity Note, Stock Split, Conversion Ratio | pure | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 |
| us-gaap | StockIssuedDuringPeriodSharesAcquisitions | Stock Issued During Period, Shares, Acquisitions | shares | 310,431 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-28 | 0000950170-24-038064 |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | Stock Issued During Period, Value, Conversion of Convertible Securities | USD | 62.07M | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-03-27 | 0000950170-25-046035 |
| us-gaap | StockIssuedDuringPeriodValueIssuedForServices | Stock Issued During Period, Value, Issued for Services | USD | 8,000 | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-28 | 0000950170-24-038064 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 31,000 | 2026-04-01 | 2026-06-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 25,000 | 2025-07-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 |
| us-gaap | SupplementalUnemploymentBenefitsSeveranceBenefits | Supplemental Unemployment Benefits, Severance Benefits | USD | 3.75M | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-12 | 0000950170-23-021775 | |
| us-gaap | TemporaryEquityCarryingAmountAttributableToParent | Temporary Equity, Carrying Amount, Attributable to Parent | USD | 131.36M | 2019-12-31 | 2021 | FY | 10-K | 2022-03-11 | 0001564590-22-009728 | |
| us-gaap | TemporaryEquityDividendsAdjustment | Temporary Equity, Dividends, Adjustment | USD | 7.19M | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-11 | 0001564590-22-009728 |
| us-gaap | TemporaryEquityLiquidationPreference | Temporary Equity, Liquidation Preference | USD | 148.59M | 2019-12-31 | 2021 | FY | 10-K | 2022-03-11 | 0001564590-22-009728 | |
| us-gaap | TemporaryEquitySharesAuthorized | Temporary Equity, Shares Authorized | shares | 142.15M | 2019-12-31 | 2021 | FY | 10-K | 2022-03-11 | 0001564590-22-009728 | |
| us-gaap | TemporaryEquitySharesOutstanding | Temporary Equity, Shares Outstanding | shares | 0 | 2020-09-29 | 2021 | FY | 10-K | 2022-03-11 | 0001564590-22-009728 | |
| us-gaap | UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic | Undistributed Earnings (Loss) Allocated to Participating Securities, Basic | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-28 | 0000950170-24-038064 |
| us-gaap | UnrealizedGainLossOnInvestments | Unrealized Gain (Loss) on Investments | USD | 1,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001193125-26-088147 |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 5.17M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001193125-26-088147 | |
| us-gaap | UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions | Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions | USD | 9.56M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001193125-26-088147 |
| us-gaap | UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued | Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001193125-26-088147 | |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition | Unrecognized Tax Benefits, Increase Resulting from Acquisition | USD | 847,000 | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-03-27 | 0000950170-25-046035 |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions | USD | 345,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001193125-26-088147 |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions | USD | 2.91M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001193125-26-088147 |
| us-gaap | VariableInterestEntityOwnershipPercentage | Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage | pure | 0.05 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 |
| us-gaap | VariableLeaseCost | Variable Lease, Cost | USD | 500,000 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0000950170-23-006795 |
| us-gaap | WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount1 | WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount1 | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-27 | 0000950170-25-046035 |
| us-gaap | WarrantsAndRightsOutstanding | Warrants and Rights Outstanding | USD | 796,000 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-11 | 0000950170-23-041844 | |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 4.51M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 |
| us-gaap | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 21.36M | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-12 | 0001564590-22-019611 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 4.51M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455490 |